• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征:内分泌科医生与妇科医生在诊断和管理方面的显著差异。

Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management.

作者信息

Cussons Andrea J, Stuckey Bronwyn G A, Walsh John P, Burke Valerie, Norman Robert J

机构信息

Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

出版信息

Clin Endocrinol (Oxf). 2005 Mar;62(3):289-95. doi: 10.1111/j.1365-2265.2004.02208.x.

DOI:10.1111/j.1365-2265.2004.02208.x
PMID:15730409
Abstract

BACKGROUND

Women with polycystic ovarian syndrome (PCOS) commonly consult endocrinologists or gynaecologists and it is not known whether these specialty groups differ in their approach to management.

OBJECTIVE

To compare the investigation, diagnosis and treatment practices of endocrinologists and gynaecologists who treat PCOS.

DESIGN AND SETTING

A mailed questionnaire containing a hypothetical patient's case history with varying presentations--oligomenorrhoea, hirsutism, infertility and obesity--was sent to Australian clinical endocrinologists and gynaecologists in teaching hospitals and private practice.

RESULTS

Evaluable responses were obtained from 138 endocrinologists and 172 gynaecologists. The two specialty groups differed in their choice of essential diagnostic criteria and investigations. Endocrinologists regarded androgenization (81%) and menstrual irregularity (70%) as essential diagnostic criteria, whereas gynaecologists required polycystic ovaries (61%), androgenization (59%), menstrual irregularity (47%) and an elevated LH/FSH ratio (47%) (all P-values < 0.001). In investigation, gynaecologists were more likely to request ovarian ultrasound (91%vs. 44%, P < 0.001) and endocrinologists more likely to measure adrenal androgens (80%vs. 58%, P < 0.001) and lipids (67%vs. 34%, P < 0.001). Gynaecologists were less likely to assess glucose homeostasis but more likely to use a glucose tolerance test to do so. Diet and exercise were chosen by most respondents as first-line treatment for all presentations. However, endocrinologists were more likely to use insulin sensitizers, particularly metformin, for these indications. In particular, for infertility, endocrinologists favoured metformin treatment whereas gynaecologists recommended clomiphene.

CONCLUSIONS

There is a lack of consensus between endocrinologists and gynaecologists in the definition, diagnosis and treatment of PCOS. As a consequence, women may receive a different diagnosis or treatment depending on the type of specialist consulted.

摘要

背景

多囊卵巢综合征(PCOS)女性通常会咨询内分泌科医生或妇科医生,目前尚不清楚这些专科群体在治疗方法上是否存在差异。

目的

比较治疗PCOS的内分泌科医生和妇科医生的检查、诊断及治疗方法。

设计与地点

向澳大利亚教学医院和私人诊所的临床内分泌科医生和妇科医生发送了一份包含假设患者不同临床表现(月经过少、多毛、不孕和肥胖)病史的邮寄问卷。

结果

获得了138名内分泌科医生和172名妇科医生的可评估回复。两个专科群体在基本诊断标准和检查的选择上存在差异。内分泌科医生将雄激素化(81%)和月经不规律(70%)视为基本诊断标准,而妇科医生则要求多囊卵巢(61%)、雄激素化(59%)、月经不规律(47%)以及LH/FSH比值升高(47%)(所有P值<0.001)。在检查方面,妇科医生更倾向于要求进行卵巢超声检查(91%对44%,P<0.001),而内分泌科医生更倾向于检测肾上腺雄激素(80%对58%,P<0.001)和血脂(67%对34%,P<0.001)。妇科医生评估葡萄糖稳态的可能性较小,但更倾向于使用葡萄糖耐量试验进行评估。大多数受访者选择饮食和运动作为所有临床表现的一线治疗方法。然而,内分泌科医生更倾向于使用胰岛素增敏剂,尤其是二甲双胍来治疗这些病症。特别是对于不孕,内分泌科医生更倾向于使用二甲双胍治疗,而妇科医生则推荐使用克罗米芬。

结论

内分泌科医生和妇科医生在PCOS的定义、诊断和治疗方面缺乏共识。因此,女性根据咨询的专科医生类型可能会得到不同的诊断或治疗。

相似文献

1
Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management.多囊卵巢综合征:内分泌科医生与妇科医生在诊断和管理方面的显著差异。
Clin Endocrinol (Oxf). 2005 Mar;62(3):289-95. doi: 10.1111/j.1365-2265.2004.02208.x.
2
Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.基于鹿特丹标准的多囊卵巢综合征病例与仅有少排卵/无排卵或多毛症等临床体征的女性的临床和实验室特征比较。
Arch Gynecol Obstet. 2006 Jul;274(4):227-32. doi: 10.1007/s00404-006-0173-8. Epub 2006 May 12.
3
[Exploration of the classification of polycystic ovarian syndrome].[多囊卵巢综合征的分类探索]
Zhonghua Fu Chan Ke Za Zhi. 2006 Oct;41(10):684-8.
4
Disparity among Endocrinologists and Gynaecologists in the Diagnosis of Polycystic Ovarian Syndrome.内分泌学家和妇科医生在多囊卵巢综合征诊断中的差异。
Sultan Qaboos Univ Med J. 2020 Aug;20(3):e323-e329. doi: 10.18295/squmj.2020.20.03.012. Epub 2020 Oct 5.
5
European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire.欧洲多囊卵巢综合征的诊断和管理调查:ESE PCOS 特别兴趣小组问卷调查结果。
Eur J Endocrinol. 2014 Oct;171(4):489-98. doi: 10.1530/EJE-14-0252. Epub 2014 Jul 21.
6
Trends in standard workup performed by pediatric subspecialists for the diagnosis of adolescent polycystic ovary syndrome.儿科亚专科医生用于诊断青少年多囊卵巢综合征的标准检查方法的趋势。
J Pediatr Adolesc Gynecol. 2015 Feb;28(1):43-46. doi: 10.1016/j.jpag.2014.03.002. Epub 2014 Mar 15.
7
Approach to adolescent polycystic ovary syndrome (PCOS) in the pediatric endocrine community in the U.S.A.美国儿科内分泌学界对青少年多囊卵巢综合征(PCOS)的诊疗方法
J Pediatr Endocrinol Metab. 2005 May;18(5):499-506. doi: 10.1515/jpem.2005.18.5.499.
8
The polycystic ovary syndrome. 1. Pathogenesis.
Br J Hosp Med. 1994;51(4):167-74.
9
The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.评估代谢参数和胰岛素敏感性以更可靠地诊断多囊卵巢综合征。
Clin Endocrinol (Oxf). 2008 Jul;69(1):52-60. doi: 10.1111/j.1365-2265.2007.03145.x. Epub 2008 Jul 1.
10
Trends, in Diagnosis and Treatment of Polycystic Ovarian Syndrome by Specialty.按专业划分的多囊卵巢综合征诊断与治疗趋势
J Reprod Med. 2016 Sep;61(9-10):441-446.

引用本文的文献

1
Sex modifies the effect of genetic risk scores for polycystic ovary syndrome on metabolic phenotypes.性别会改变多囊卵巢综合征遗传风险评分对代谢表型的影响。
PLoS Genet. 2023 May 31;19(5):e1010764. doi: 10.1371/journal.pgen.1010764. eCollection 2023 May.
2
Study of Burden in Polycystic Ovary Syndrome at Global, Regional, and National Levels from 1990 to 2019.1990年至2019年全球、区域和国家层面多囊卵巢综合征负担研究
Healthcare (Basel). 2023 Feb 14;11(4):562. doi: 10.3390/healthcare11040562.
3
Evidence-Based Lifestyle Guidelines and Self-Management Strategies Utilized by Women with Polycystic Ovary Syndrome.
多囊卵巢综合征女性采用的循证生活方式指南和自我管理策略。
Nutrients. 2023 Jan 22;15(3):589. doi: 10.3390/nu15030589.
4
The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health.雄激素在人体中的作用:生物学、代谢调节与健康。
Int J Mol Sci. 2022 Oct 8;23(19):11952. doi: 10.3390/ijms231911952.
5
Polycystic ovary syndrome: An exploration of unmarried women's knowledge and attitudes.多囊卵巢综合征:未婚女性的知识与态度探究
Heliyon. 2022 Jun 30;8(7):e09835. doi: 10.1016/j.heliyon.2022.e09835. eCollection 2022 Jul.
6
Implementation of international guidelines for polycystic ovary syndrome: barriers and facilitators among gynecologists and primary care providers.多囊卵巢综合征国际指南的实施:妇科医生和初级保健提供者面临的障碍与促进因素
F S Rep. 2022 Jan 25;3(2):94-101. doi: 10.1016/j.xfre.2022.01.005. eCollection 2022 Jun.
7
The effect of low glycemic index diet on the reproductive and clinical profile in women with polycystic ovarian syndrome: A systematic review and meta-analysis.低血糖指数饮食对多囊卵巢综合征女性生殖及临床特征的影响:一项系统评价与荟萃分析。
Heliyon. 2021 Nov 9;7(11):e08338. doi: 10.1016/j.heliyon.2021.e08338. eCollection 2021 Nov.
8
Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success.为多囊卵巢综合征患者提供生活方式建议:影响成功的实际问题概述。
BMC Endocr Disord. 2021 Nov 23;21(1):234. doi: 10.1186/s12902-021-00890-8.
9
Obesity management in polycystic ovary syndrome: disparity in knowledge between obstetrician-gynecologists and reproductive endocrinologists in China.多囊卵巢综合征的肥胖管理:中国妇产科医生和生殖内分泌学家之间知识的差距。
BMC Endocr Disord. 2021 Sep 6;21(1):182. doi: 10.1186/s12902-021-00848-w.
10
Disparity among Endocrinologists and Gynaecologists in the Diagnosis of Polycystic Ovarian Syndrome.内分泌学家和妇科医生在多囊卵巢综合征诊断中的差异。
Sultan Qaboos Univ Med J. 2020 Aug;20(3):e323-e329. doi: 10.18295/squmj.2020.20.03.012. Epub 2020 Oct 5.